These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38246725)

  • 21. MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL-Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway.
    Wang Y; Li X; Zhou S; Li J; Zhu Y; Wang Q; Zhao F
    Oxid Med Cell Longev; 2022; 2022():7727006. PubMed ID: 36148414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling.
    Hu B; Sun X; Yang Y; Ying Z; Meng J; Zhou C; Jiang G; Li S; Wu F; Zhao X; Zhu H; Wu H; Cai X; Shi Z; Yan S
    FASEB J; 2019 Feb; 33(2):2574-2586. PubMed ID: 30285579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss.
    Ma L; Zhang L; Liao Z; Xiu C; Luo X; Luo N; Zhang L; He G; Chen J
    J Orthop Translat; 2023 Sep; 42():1-14. PubMed ID: 37521493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
    Liu FL; Chen CL; Lai CC; Lee CC; Chang DM
    Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis.
    Liu Z; Liang W; Kang D; Chen Q; Ouyang Z; Yan H; Huang B; Jin D; Chen Y; Li Q
    Clin Interv Aging; 2020; 15():1201-1212. PubMed ID: 32764906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization.
    Shim KS; Lee B; Ma JY
    BMC Complement Altern Med; 2017 Oct; 17(1):483. PubMed ID: 29070038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Menaquinone-4 on Receptor Activator of Nuclear Factor
    Lee AS; Sung MJ; Son SJ; Han AR; Hong SM; Lee SH
    J Med Food; 2023 Feb; 26(2):128-134. PubMed ID: 36724309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism.
    Jia Y; Jiang J; Lu X; Zhang T; Zhao K; Han W; Yang W; Qian Y
    J Cell Physiol; 2019 May; 234(5):7498-7509. PubMed ID: 30471112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.
    Ha H; Shim KS; An H; Kim T; Ma JY
    BMC Complement Altern Med; 2013 May; 13():112. PubMed ID: 23692684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
    Rahman MM; Bhattacharya A; Fernandes G
    J Lipid Res; 2006 Aug; 47(8):1739-48. PubMed ID: 16702601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactin suppresses osteoclastogenesis via the NF-κB signaling pathway, promotes osteogenic differentiation in vitro, and inhibits oestrogen deficiency-induced bone loss in vivo.
    Kuang Z; Yang X; Cao Z; Li Y; Hu J; Hong X; Li B; Wu C; Qi Q; Liu X; Dai M
    Int Immunopharmacol; 2023 Apr; 117():109884. PubMed ID: 36805201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis.
    Ye X; Jiang J; Yang J; Yan W; Jiang L; Chen Y
    Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(8):1080-1089. PubMed ID: 35929595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY; Lee KH; Kim YK
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor α.
    Wang L; Qiu XM; Gui YY; Xu YP; Gober HJ; Li DJ
    Drug Des Devel Ther; 2015; 9():3755-66. PubMed ID: 26229438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation.
    Zhuang J; Ning H; Wang M; Zhao W; Jing Y; Liu X; Zu J; Kong P; Wang X; Sun C; Yan J
    Cell Signal; 2021 Nov; 87():110137. PubMed ID: 34469786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss.
    Han SY; Kim YK
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Si-Zhi Wan regulates osteoclast autophagy in osteoporosis through the AMPK signaling pathway to attenuate osteoclastogenesis.
    Huang Y; Yao H; Tjahjono AW; Xiang L; Li K; Tang J; Gao Y
    J Pharm Pharmacol; 2024 Mar; 76(3):236-244. PubMed ID: 38183672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation.
    Wu G; Pan L; Sun J; Chen G; Wang S
    Menopause; 2019 Jul; 26(7):785-792. PubMed ID: 31083022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anacardic acid inhibits RANKL-induced osteoclastogenesis
    Zhao K; Jia Y; Peng J; Pang C; Zhang T; Han W; Jiang J; Lu X; Zhu J; Qian Y
    FASEB J; 2019 Aug; 33(8):9100-9115. PubMed ID: 31050917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.